RP 705 (Amphetamine and Dextroamphetamine Extended Release 5 mg)
Pill with imprint RP 705 is Blue / Beige, Capsule-shape and has been identified as Amphetamine and Dextroamphetamine Extended Release 5 mg. It is supplied by Rhodes Pharmaceuticals.
Amphetamine/dextroamphetamine is used in the treatment of adhd; narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Amphetamine/dextroamphetamine 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for RP 705
Amphetamine and Dextroamphetamine Extended Release
- Imprint
- RP 705
- Strength
- 5 mg
- Color
- Blue / Beige
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Rhodes Pharmaceuticals
- National Drug Code (NDC)
- 42858-0055
More about amphetamine / dextroamphetamine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (1,009)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: CNS stimulants
Patient resources
- Drug Information
- Dextroamphetamine and amphetamine (Advanced Reading)
- Dextroamphetamine and Amphetamine Tablets
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
Other brands
Adderall, Adderall XR, Mydayis
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.